TRUVADA - 55154-4425-0 - (emtricitabine and tenofovir disoproxil fumarate)

Alphabetical Index


Drug Information of TRUVADA

Product NDC: 55154-4425
Proprietary Name: TRUVADA
Non Proprietary Name: emtricitabine and tenofovir disoproxil fumarate
Active Ingredient(s): 200; 300    mg/1; mg/1 & nbsp;   emtricitabine and tenofovir disoproxil fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of TRUVADA

Product NDC: 55154-4425
Labeler Name: Cardinal Health
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021752
Marketing Category: NDA
Start Marketing Date: 20040802

Package Information of TRUVADA

Package NDC: 55154-4425-0
Package Description: 10 POUCH in 1 BAG (55154-4425-0) > 1 TABLET, FILM COATED in 1 POUCH

NDC Information of TRUVADA

NDC Code 55154-4425-0
Proprietary Name TRUVADA
Package Description 10 POUCH in 1 BAG (55154-4425-0) > 1 TABLET, FILM COATED in 1 POUCH
Product NDC 55154-4425
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name emtricitabine and tenofovir disoproxil fumarate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20040802
Marketing Category Name NDA
Labeler Name Cardinal Health
Substance Name EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Strength Number 200; 300
Strength Unit mg/1; mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of TRUVADA


General Information